BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 33731701)

  • 1. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
    Zhang B; Li Y; Wu Q; Xie L; Barwick B; Fu C; Li X; Wu D; Xia S; Chen J; Qian WP; Yang L; Osunkoya AO; Boise L; Vertino PM; Zhao Y; Li M; Chen HR; Kowalski J; Kucuk O; Zhou W; Dong JT
    Nat Commun; 2021 Mar; 12(1):1714. PubMed ID: 33731701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
    Huang Q; Liu M; Zhang D; Lin BB; Fu X; Zhang Z; Zhang B; Dong JT
    BMC Med; 2023 Feb; 21(1):68. PubMed ID: 36810084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
    Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.
    Jia J; Zhang HB; Shi Q; Yang C; Ma JB; Jin B; Wang X; He D; Guo P
    Theranostics; 2019; 9(19):5464-5477. PubMed ID: 31534497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth.
    Festuccia C; Mancini A; Gravina GL; Colapietro A; Vetuschi A; Pompili S; Ventura L; Delle Monache S; Iorio R; Del Fattore A; Fogler W; Magnani J
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
    Che M; Chaturvedi A; Munro SA; Pitzen SP; Ling A; Zhang W; Mentzer J; Ku SY; Puca L; Zhu Y; Bergman AM; Severson TM; Forster C; Liu Y; Hildebrand J; Daniel M; Wang TY; Selth LA; Hickey T; Zoubeidi A; Gleave M; Bareja R; Sboner A; Tilley W; Carroll JS; Tan W; Kohli M; Yang R; Hsieh AC; Murugan P; Zwart W; Beltran H; Huang RS; Dehm SM
    Nat Commun; 2021 Nov; 12(1):6377. PubMed ID: 34737261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells.
    Zhao T; Liu C; Chen L
    PLoS One; 2015; 10(9):e0138168. PubMed ID: 26372456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.
    Guo P; Xing C; Fu X; He D; Dong JT
    J Cell Biochem; 2020 Mar; 121(3):2197-2208. PubMed ID: 31724223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.
    Zhang B; Zhang Z; Xia S; Xing C; Ci X; Li X; Zhao R; Tian S; Ma G; Zhu Z; Fu L; Dong JT
    Mol Cell Biol; 2013 Dec; 33(24):4919-35. PubMed ID: 24126055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Macrophage Promotes the Survival of Cancer Cells upon Docetaxel Chemotherapy via the CSF1/CSF1R-CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer.
    Guan W; Li F; Zhao Z; Zhang Z; Hu J; Zhang Y
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
    Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
    J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.
    Li X; Zhang B; Wu Q; Ci X; Zhao R; Zhang Z; Xia S; Su D; Chen J; Ma G; Fu L; Dong JT
    Int J Cancer; 2015 Feb; 136(3):536-46. PubMed ID: 24931571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
    Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
    Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification.
    Guo P; Dong XY; Zhang X; Zhao KW; Sun X; Li Q; Dong JT
    J Biol Chem; 2009 Mar; 284(10):6071-8. PubMed ID: 19056724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone Has Limited Activity to Enhance the
    Yang Y; Li X; Mamouni K; Kucuk O; Wu D
    Anticancer Res; 2017 Nov; 37(11):6235-6243. PubMed ID: 29061806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells.
    Xing C; Fu X; Sun X; Guo P; Li M; Dong JT
    PLoS One; 2013; 8(6):e65538. PubMed ID: 23755247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.
    Haider M; Zhang X; Coleman I; Ericson N; True LD; Lam HM; Brown LG; Ketchanji M; Nghiem B; Lakely B; Coleman R; Montgomery B; Lange PH; Roudier M; Higano CS; Bielas JH; Nelson PS; Vessella RL; Morrissey C
    Clin Exp Metastasis; 2016 Mar; 33(3):239-48. PubMed ID: 26667932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration.
    Zhang B; Ci X; Tao R; Ni JJ; Xuan X; King JL; Xia S; Li Y; Frierson HF; Lee DK; Xu J; Osunkoya AO; Dong JT
    Nat Commun; 2020 Feb; 11(1):997. PubMed ID: 32081850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.